Dr Lin on the Safety of T-DXd for HER2+ Breast Cancer With/Without Brain Metastases
Nancy U. Lin, MD, associate chief, Division of Breast Oncology, Dana-Farber Cancer Institute, Susan F. Smith Center for Women’s Cancers, director, Metastatic Breast Cancer Program, Program for Patients with Breast Cancer Brain Metastases, senior physician, …